FDA Says to Stop Selling Vaginal Mesh

An increase in ‘adverse events’ linked to surgical mesh used in pelvic procedures prompts action from the FDA.

FDA / Image: Andrew Harnik
FDA / Image: Andrew Harnik

For the past few years, the FDA has been investigating the safety of surgical mesh used for repairing a condition called pelvic organ prolapse. A recent article from The Washington Post contained the latest development stating that the FDA has ordered manufacturers to immediately stop selling the products. This includes Boston Scientific and Coloplast, neither of which has demonstrated a “reasonable assurance” of safety and effectiveness for long-term use of the devices. The companies have 10 days to submit plans for withdrawing them from the market.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report